Forgot your password?

Forgot your username?

database > company
Mast Therapeutics, Inc.
Biotech Specialty Pharma
12390 El Camino Real, Suite 150
San Diego, CA 92130 United States
phone:phone
fax:fax
Click for website
Research Sector Biotech Specialty Pharma
Summary Description
Hematology and oncology-focused biopharmaceutical company with three clinical-stage product candidates.
Click here for Financial Data
Keywords
sickle cell disease, microvascular, hematology, oncology, shock, copolymer, chemotherapy, nonsmallcelllungcancer, lungcancer, breastcancer, solidtumor, cytoprotective, ischemia, acutelimbischemia



Description

Mast Therapeutics, Inc. (NYSE MKT: MSTX) is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging the MAST (Molecular Adhesion and Sealant Tech......view more

Products / Services

Mast's lead product candidate, MST-188 (formerly ANX-188) is a purified form of a nonionic, triblock copolymer (poloxamer 188). It binds to hydrophobic surfaces on damaged cells and improves membrane ......view more


Technology / Differentiation

MST-188 is an investigational agent, formulated using a purified form of poloxamer 188. Substantial research has demonstrated that poloxamer 188 has cytoprotective and hemorrheologic properties and in...view more

Status

- The company is currently recruiting patients with sickle cell disease to participate in EPIC, its phase 3 trial of MST-188. At the end of March, 2013, the European Commission designated MST-188 as a...view more



2014-09-02-6477